| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.92e-07 | 188 | 66 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | SLIT2 NID2 HSPG2 FAT4 SCUBE1 SHH LTBP2 CUBN FLG2 LRP1B PCDH17 RYR1 CAPN11 | 8.55e-07 | 749 | 66 | 13 | GO:0005509 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.87e-05 | 268 | 66 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | heparin binding | 4.11e-05 | 192 | 66 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 1.07e-04 | 5 | 66 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 1.19e-04 | 29 | 66 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | collagen binding | 1.50e-04 | 81 | 66 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | laminin-1 binding | 2.97e-04 | 8 | 66 | 2 | GO:0043237 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 3.82e-04 | 9 | 66 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.41e-04 | 51 | 66 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 6.87e-04 | 323 | 66 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 8.20e-04 | 13 | 66 | 2 | GO:0061459 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.30e-03 | 65 | 66 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.82e-03 | 73 | 66 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.97e-03 | 20 | 66 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.54e-03 | 891 | 66 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.81e-03 | 85 | 66 | 3 | GO:0019199 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | SLIT2 NID2 HSPG2 PRTN3 COL17A1 SHH LAMB1 PCOLCE2 LTBP2 SSPOP | 7.84e-06 | 530 | 68 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | SLIT2 NID2 HSPG2 PRTN3 COL17A1 LRIG1 SHH LAMB1 PCOLCE2 LTBP2 SSPOP | 8.06e-06 | 656 | 68 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | SLIT2 NID2 HSPG2 PRTN3 COL17A1 LRIG1 SHH LAMB1 PCOLCE2 LTBP2 SSPOP | 8.30e-06 | 658 | 68 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 6.74e-04 | 122 | 68 | 4 | GO:0005604 | |
| Domain | EGF_2 | SLIT2 NID2 HSPG2 FAT4 SCUBE1 LAMB1 LRP5 LTBP2 CUBN LRP1B SSPOP EPHA1 | 1.87e-10 | 265 | 68 | 12 | PS01186 |
| Domain | Growth_fac_rcpt_ | 2.37e-10 | 156 | 68 | 10 | IPR009030 | |
| Domain | EGF-like_Ca-bd_dom | 6.62e-10 | 124 | 68 | 9 | IPR001881 | |
| Domain | EGF-like_CS | SLIT2 NID2 HSPG2 FAT4 SCUBE1 LAMB1 LRP5 LTBP2 CUBN LRP1B EPHA1 | 2.44e-09 | 261 | 68 | 11 | IPR013032 |
| Domain | EGF_CA | 2.66e-09 | 99 | 68 | 8 | PS01187 | |
| Domain | EGF_3 | 1.26e-08 | 235 | 68 | 10 | PS50026 | |
| Domain | EGF | 1.26e-08 | 235 | 68 | 10 | SM00181 | |
| Domain | EGF_CA | 1.40e-08 | 122 | 68 | 8 | SM00179 | |
| Domain | EGF-like_dom | 2.19e-08 | 249 | 68 | 10 | IPR000742 | |
| Domain | EGF_1 | 2.74e-08 | 255 | 68 | 10 | PS00022 | |
| Domain | EGF_Ca-bd_CS | 6.13e-08 | 97 | 68 | 7 | IPR018097 | |
| Domain | ASX_HYDROXYL | 7.57e-08 | 100 | 68 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.13e-07 | 106 | 68 | 7 | IPR000152 | |
| Domain | EGF | 3.71e-07 | 126 | 68 | 7 | PF00008 | |
| Domain | EGF_CA | 6.96e-07 | 86 | 68 | 6 | PF07645 | |
| Domain | EGF_3 | 9.92e-06 | 12 | 68 | 3 | PF12947 | |
| Domain | EGF_dom | 9.92e-06 | 12 | 68 | 3 | IPR024731 | |
| Domain | LDLR_class-A_CS | 1.33e-05 | 40 | 68 | 4 | IPR023415 | |
| Domain | Ldl_recept_b | 1.63e-05 | 14 | 68 | 3 | PF00058 | |
| Domain | LDLRB | 1.63e-05 | 14 | 68 | 3 | PS51120 | |
| Domain | LY | 2.04e-05 | 15 | 68 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.04e-05 | 15 | 68 | 3 | IPR000033 | |
| Domain | Ldl_recept_a | 2.14e-05 | 45 | 68 | 4 | PF00057 | |
| Domain | - | 2.34e-05 | 46 | 68 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.77e-05 | 48 | 68 | 4 | PS01209 | |
| Domain | CUB | 3.01e-05 | 49 | 68 | 4 | PF00431 | |
| Domain | LDLRA_2 | 3.01e-05 | 49 | 68 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 3.01e-05 | 49 | 68 | 4 | IPR002172 | |
| Domain | LDLa | 3.01e-05 | 49 | 68 | 4 | SM00192 | |
| Domain | CUB | 3.26e-05 | 50 | 68 | 4 | SM00042 | |
| Domain | - | 3.81e-05 | 52 | 68 | 4 | 2.60.120.290 | |
| Domain | CUB | 4.11e-05 | 53 | 68 | 4 | PS01180 | |
| Domain | CUB_dom | 5.49e-05 | 57 | 68 | 4 | IPR000859 | |
| Domain | cEGF | 1.13e-04 | 26 | 68 | 3 | IPR026823 | |
| Domain | cEGF | 1.13e-04 | 26 | 68 | 3 | PF12662 | |
| Domain | NUT | 1.30e-04 | 5 | 68 | 2 | IPR024310 | |
| Domain | NUT_N | 1.30e-04 | 5 | 68 | 2 | IPR024309 | |
| Domain | NUT | 1.30e-04 | 5 | 68 | 2 | PF12881 | |
| Domain | LAM_G_DOMAIN | 3.55e-04 | 38 | 68 | 3 | PS50025 | |
| Domain | - | 3.84e-04 | 39 | 68 | 3 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 4.14e-04 | 40 | 68 | 3 | PF02210 | |
| Domain | LamG | 5.49e-04 | 44 | 68 | 3 | SM00282 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.26e-04 | 46 | 68 | 3 | IPR011042 | |
| Domain | Laminin_G_1 | 7.03e-04 | 11 | 68 | 2 | PF00054 | |
| Domain | ConA-like_dom | 1.21e-03 | 219 | 68 | 5 | IPR013320 | |
| Domain | Laminin_G | 1.23e-03 | 58 | 68 | 3 | IPR001791 | |
| Domain | CTCK_1 | 1.92e-03 | 18 | 68 | 2 | PS01185 | |
| Domain | Ephrin_rec_like | 3.71e-03 | 25 | 68 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.71e-03 | 25 | 68 | 2 | IPR011641 | |
| Domain | Cys_knot_C | 3.71e-03 | 25 | 68 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.71e-03 | 25 | 68 | 2 | PS01225 | |
| Domain | TyrKc | 4.06e-03 | 88 | 68 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 4.06e-03 | 88 | 68 | 3 | IPR020635 | |
| Domain | hEGF | 4.64e-03 | 28 | 68 | 2 | PF12661 | |
| Domain | Aden_trnslctor | 4.64e-03 | 28 | 68 | 2 | IPR002113 | |
| Domain | Galactose-bd-like | 4.88e-03 | 94 | 68 | 3 | IPR008979 | |
| Domain | - | 5.03e-03 | 95 | 68 | 3 | 2.60.120.200 | |
| Domain | Ig_I-set | 5.09e-03 | 190 | 68 | 4 | IPR013098 | |
| Domain | I-set | 5.09e-03 | 190 | 68 | 4 | PF07679 | |
| Domain | EGF_LAM_2 | 5.32e-03 | 30 | 68 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 5.32e-03 | 30 | 68 | 2 | PS01248 | |
| Domain | PROTEIN_KINASE_TYR | 5.33e-03 | 97 | 68 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.33e-03 | 97 | 68 | 3 | IPR008266 | |
| Domain | LRRCT | 6.04e-03 | 32 | 68 | 2 | PF01463 | |
| Domain | EF-hand_8 | 6.80e-03 | 34 | 68 | 2 | PF13833 | |
| Domain | Laminin_EGF | 7.19e-03 | 35 | 68 | 2 | PF00053 | |
| Domain | EGF_Lam | 7.19e-03 | 35 | 68 | 2 | SM00180 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 HSPG2 SCUBE1 COL17A1 PTPRS ITGA10 LAMB1 PCOLCE2 LTBP2 CAPN11 | 2.06e-07 | 300 | 55 | 10 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.08e-05 | 258 | 55 | 7 | MM14572 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.10e-04 | 140 | 55 | 5 | M587 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.12e-04 | 30 | 55 | 3 | M27216 | |
| Pubmed | 2.13e-07 | 64 | 71 | 5 | 22261194 | ||
| Pubmed | 4.53e-07 | 8 | 71 | 3 | 12015298 | ||
| Pubmed | 1.33e-06 | 11 | 71 | 3 | 24639464 | ||
| Pubmed | 1.63e-06 | 175 | 71 | 6 | 28071719 | ||
| Pubmed | 2.92e-06 | 14 | 71 | 3 | 19783738 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.64e-06 | 15 | 71 | 3 | 15895400 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12948741 | ||
| Pubmed | Characterization of two azurphil granule proteases with active-site homology to neutrophil elastase. | 4.11e-06 | 2 | 71 | 2 | 2404977 | |
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 22262851 | ||
| Pubmed | 4.11e-06 | 2 | 71 | 2 | 12807890 | ||
| Pubmed | Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signalling. | 4.48e-06 | 16 | 71 | 3 | 35132078 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 FAT4 PTPRS FHOD1 LAMB1 LRP5 PCOLCE2 TTC13 LTBP2 LRP1B GALNT4 DCAF12 | 5.31e-06 | 1201 | 71 | 12 | 35696571 |
| Pubmed | 6.51e-06 | 18 | 71 | 3 | 12571105 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 22456610 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 12135665 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 38051393 | ||
| Pubmed | 1.23e-05 | 3 | 71 | 2 | 1518849 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 23336661 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 30089653 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 31087761 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 26056142 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 38941190 | ||
| Pubmed | 2.46e-05 | 4 | 71 | 2 | 21135133 | ||
| Pubmed | 2.87e-05 | 29 | 71 | 3 | 22613833 | ||
| Pubmed | 3.37e-05 | 608 | 71 | 8 | 16713569 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 23383134 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 31857346 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 12243745 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 11493006 | ||
| Pubmed | 4.09e-05 | 5 | 71 | 2 | 30862798 | ||
| Pubmed | Lung epithelial branching program antagonizes alveolar differentiation. | 4.26e-05 | 33 | 71 | 3 | 24058167 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.79e-05 | 97 | 71 | 4 | 27559042 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 5.61e-05 | 101 | 71 | 4 | 20551380 | |
| Pubmed | 6.13e-05 | 6 | 71 | 2 | 11956183 | ||
| Pubmed | Nidogen-2: a new basement membrane protein with diverse binding properties. | 6.13e-05 | 6 | 71 | 2 | 9733643 | |
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 6.13e-05 | 6 | 71 | 2 | 10544250 | |
| Pubmed | 7.63e-05 | 40 | 71 | 3 | 30898150 | ||
| Pubmed | The murine homeobox genes Nkx2.3 and Nkx2.6 are located on chromosomes 19 and 14, respectively. | 8.57e-05 | 7 | 71 | 2 | 8001981 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 26837596 | ||
| Pubmed | YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. | 8.57e-05 | 7 | 71 | 2 | 30582452 | |
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 25639508 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 10603087 | ||
| Pubmed | 8.57e-05 | 7 | 71 | 2 | 15183724 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 32259481 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 11847210 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 2501794 | ||
| Pubmed | 1.14e-04 | 8 | 71 | 2 | 18701067 | ||
| Pubmed | 1.32e-04 | 126 | 71 | 4 | 24319055 | ||
| Pubmed | 1.40e-04 | 49 | 71 | 3 | 21362503 | ||
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 25842978 | ||
| Pubmed | Cleavage of nidogen-1 by cathepsin S impairs its binding to basement membrane partners. | 1.47e-04 | 9 | 71 | 2 | 22952693 | |
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 33947861 | ||
| Pubmed | 1.47e-04 | 9 | 71 | 2 | 15081423 | ||
| Pubmed | A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning. | 1.47e-04 | 9 | 71 | 2 | 14530295 | |
| Pubmed | Identification of the ligands of protein interaction domains through a functional approach. | 1.47e-04 | 9 | 71 | 2 | 17124247 | |
| Pubmed | An LDL-receptor-related protein mediates Wnt signalling in mice. | 1.47e-04 | 9 | 71 | 2 | 11029008 | |
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 1.49e-04 | 50 | 71 | 3 | 24191021 | |
| Pubmed | 1.49e-04 | 50 | 71 | 3 | 23658023 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.57e-04 | 248 | 71 | 5 | 24006456 | |
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 1.63e-04 | 133 | 71 | 4 | 15604093 | |
| Pubmed | The Eukaryotic Proteome Is Shaped by E3 Ubiquitin Ligases Targeting C-Terminal Degrons. | 1.83e-04 | 10 | 71 | 2 | 29779948 | |
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.83e-04 | 10 | 71 | 2 | 16100707 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 1.83e-04 | 10 | 71 | 2 | 16554364 | |
| Pubmed | 1.85e-04 | 257 | 71 | 5 | 16335952 | ||
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 2.09e-04 | 142 | 71 | 4 | 19851296 | |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 2.15e-04 | 143 | 71 | 4 | 20198315 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 2.23e-04 | 11 | 71 | 2 | 38303699 | |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 2.23e-04 | 11 | 71 | 2 | 17023412 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 28239148 | ||
| Pubmed | Dchs1-Fat4 regulation of osteogenic differentiation in mouse. | 2.23e-04 | 11 | 71 | 2 | 31358536 | |
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 21705651 | ||
| Pubmed | 2.23e-04 | 11 | 71 | 2 | 23487314 | ||
| Pubmed | 2.33e-04 | 146 | 71 | 4 | 27068509 | ||
| Pubmed | 2.57e-04 | 432 | 71 | 6 | 7671812 | ||
| Pubmed | Roundabout receptors are critical for foregut separation from the body wall. | 2.68e-04 | 12 | 71 | 2 | 23328398 | |
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 26156498 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 22072575 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 11830575 | ||
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 30883226 | ||
| Pubmed | Molecular dynamics of Dkk4 modulates Wnt action and regulates meibomian gland development. | 2.68e-04 | 12 | 71 | 2 | 27864382 | |
| Pubmed | 2.68e-04 | 12 | 71 | 2 | 16024816 | ||
| Pubmed | 2.94e-04 | 284 | 71 | 5 | 15057824 | ||
| Pubmed | 2.97e-04 | 63 | 71 | 3 | 11572484 | ||
| Pubmed | 3.05e-04 | 446 | 71 | 6 | 24255178 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 12682087 | ||
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 3.16e-04 | 13 | 71 | 2 | 18356808 | |
| Pubmed | VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance. | 3.16e-04 | 13 | 71 | 2 | 31461654 | |
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 33144400 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 33060128 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 25366972 | ||
| Pubmed | 3.16e-04 | 13 | 71 | 2 | 30332639 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 3.22e-04 | 1070 | 71 | 9 | 23533145 | |
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 3.68e-04 | 14 | 71 | 2 | 28724790 | |
| Pubmed | 3.68e-04 | 14 | 71 | 2 | 18559345 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 3.68e-04 | 14 | 71 | 2 | 20858856 | |
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 3.68e-04 | 14 | 71 | 2 | 23217742 | |
| Pubmed | 3.88e-04 | 167 | 71 | 4 | 22159717 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 3.89e-04 | 302 | 71 | 5 | 30561431 | |
| Pubmed | A simple method for 3D analysis of immunolabeled axonal tracts in a transparent nervous system. | 4.24e-04 | 15 | 71 | 2 | 25456121 | |
| Pubmed | 4.24e-04 | 15 | 71 | 2 | 26395479 | ||
| Interaction | FBXO2 interactions | 1.30e-06 | 411 | 69 | 10 | int:FBXO2 | |
| Interaction | DEFA1 interactions | 2.38e-05 | 100 | 69 | 5 | int:DEFA1 | |
| Interaction | TXNDC2 interactions | 2.52e-05 | 17 | 69 | 3 | int:TXNDC2 | |
| GeneFamily | Low density lipoprotein receptors | 3.67e-04 | 13 | 40 | 2 | 634 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.31e-04 | 161 | 40 | 4 | 593 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.53e-03 | 40 | 40 | 2 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 5.29e-03 | 160 | 40 | 3 | 555 | |
| Coexpression | NABA_CORE_MATRISOME | 6.94e-07 | 270 | 71 | 8 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 7.97e-07 | 275 | 71 | 8 | M5884 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 8.47e-06 | 15 | 71 | 3 | MM402 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.34e-05 | 191 | 71 | 6 | MM17059 | |
| Coexpression | NABA_MATRISOME | SLIT2 FGF23 NID2 HSPG2 SCUBE1 COL17A1 SHH LAMB1 PCOLCE2 LTBP2 FLG2 SSPOP | 1.55e-05 | 1008 | 71 | 12 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.55e-05 | 196 | 71 | 6 | M3008 | |
| Coexpression | NABA_MATRISOME | SLIT2 FGF23 NID2 HSPG2 SCUBE1 COL17A1 SHH LAMB1 PCOLCE2 LTBP2 FLG2 SSPOP | 1.84e-05 | 1026 | 71 | 12 | M5889 |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 7.04e-05 | 257 | 71 | 6 | M13867 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 8.87e-05 | 268 | 71 | 6 | M45796 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.17e-04 | 35 | 71 | 3 | MM17054 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-08 | 199 | 70 | 7 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-08 | 199 | 70 | 7 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.84e-08 | 126 | 70 | 6 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.84e-08 | 126 | 70 | 6 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.27e-07 | 182 | 70 | 6 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.66e-07 | 191 | 70 | 6 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-07 | 192 | 70 | 6 | f4cd65e6c5b17bcabf45fe5b687246c72e7975f7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-07 | 192 | 70 | 6 | bcd8876235be503186f119653b39476488c0fa15 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-07 | 194 | 70 | 6 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-07 | 194 | 70 | 6 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-07 | 194 | 70 | 6 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.39e-07 | 195 | 70 | 6 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.78e-07 | 197 | 70 | 6 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.98e-07 | 198 | 70 | 6 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 6.98e-07 | 198 | 70 | 6 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 199 | 70 | 6 | a207b4891881149d4c50721310690fd794157723 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.19e-07 | 199 | 70 | 6 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 200 | 70 | 6 | 2488aa12970a43a5af352e2c36c73884d73a1cc5 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.41e-07 | 200 | 70 | 6 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.41e-07 | 200 | 70 | 6 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 200 | 70 | 6 | ae429f2de652cc1976e63644781197e9ce0e70c8 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 200 | 70 | 6 | e786544cf6f891550c4be55ebb4928c92297b504 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.41e-07 | 200 | 70 | 6 | 49658e1b530de0dad16d45a1112bdf5329bb800d | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.53e-06 | 161 | 70 | 5 | 048b7dc00746987a24bf870d4d278c4183eb04a2 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 6.42e-06 | 166 | 70 | 5 | 20f248d95c86eb52a1efe9abe73123fbe4206caf | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 7.00e-06 | 169 | 70 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-06 | 177 | 70 | 5 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.76e-06 | 177 | 70 | 5 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 177 | 70 | 5 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.00e-06 | 178 | 70 | 5 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.00e-06 | 178 | 70 | 5 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.51e-06 | 180 | 70 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-06 | 181 | 70 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-06 | 181 | 70 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.00e-05 | 182 | 70 | 5 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 1.06e-05 | 184 | 70 | 5 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-05 | 185 | 70 | 5 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.11e-05 | 186 | 70 | 5 | e8ead5634686ebaa6a230eea69795d923ce9939d | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 186 | 70 | 5 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-05 | 186 | 70 | 5 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-05 | 186 | 70 | 5 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.14e-05 | 187 | 70 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 190 | 70 | 5 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 190 | 70 | 5 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-05 | 191 | 70 | 5 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 191 | 70 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 192 | 70 | 5 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 192 | 70 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | 5d42979d811ee13a07dee08a3743a90776017cb4 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | 95e64b9580d30c28702639a043a8b72ce1cadeb6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | 97c0730aad9135ac681250b3871cc094a28f80a7 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.33e-05 | 193 | 70 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.33e-05 | 193 | 70 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 195 | 70 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 195 | 70 | 5 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 196 | 70 | 5 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 196 | 70 | 5 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 197 | 70 | 5 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 197 | 70 | 5 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-05 | 197 | 70 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.47e-05 | 197 | 70 | 5 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-05 | 197 | 70 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 197 | 70 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.47e-05 | 197 | 70 | 5 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 197 | 70 | 5 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.47e-05 | 197 | 70 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.47e-05 | 197 | 70 | 5 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.47e-05 | 197 | 70 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 198 | 70 | 5 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 198 | 70 | 5 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-05 | 198 | 70 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 198 | 70 | 5 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 198 | 70 | 5 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 198 | 70 | 5 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 198 | 70 | 5 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-05 | 198 | 70 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.51e-05 | 198 | 70 | 5 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 198 | 70 | 5 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 199 | 70 | 5 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 199 | 70 | 5 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 199 | 70 | 5 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 199 | 70 | 5 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 199 | 70 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 199 | 70 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 199 | 70 | 5 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 199 | 70 | 5 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 199 | 70 | 5 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.58e-05 | 200 | 70 | 5 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.58e-05 | 200 | 70 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 200 | 70 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 70 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 70 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-05 | 200 | 70 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-05 | 113 | 70 | 4 | b795a0c65114b3c0758fe3720e8a80247f900971 | |
| ToppCell | COVID-19_Mild-Myeloid_G-immature_Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 3.04e-05 | 113 | 70 | 4 | fc3417c379f871a4aec3edef953baaa00755c472 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.15e-05 | 114 | 70 | 4 | 613714fd15ad6d553e63d8538ad53bc1ded6bd6c | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.42e-05 | 131 | 70 | 4 | 5b29f0dc449b9fff5e8bf6365080168f31b7e268 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.17e-05 | 150 | 70 | 4 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| Disease | ornithine translocase deficiency (implicated_via_orthology) | 5.08e-06 | 2 | 67 | 2 | DOID:0050720 (implicated_via_orthology) | |
| Disease | Endometrial Stromal Sarcoma | 5.06e-05 | 5 | 67 | 2 | C0206630 | |
| Disease | colorectal cancer | 6.64e-05 | 604 | 67 | 8 | MONDO_0005575 | |
| Disease | myeloblastin measurement | 7.57e-05 | 6 | 67 | 2 | EFO_0020585 | |
| Disease | carcinoma (implicated_via_orthology) | 4.22e-04 | 64 | 67 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | trimethylamine-N-oxide measurement | 4.54e-04 | 14 | 67 | 2 | EFO_0010541 | |
| Disease | response to radiation, Urinary retention | 6.76e-04 | 17 | 67 | 2 | GO_0009314, HP_0000016 | |
| Disease | Van Buchem disease | 6.76e-04 | 17 | 67 | 2 | C0432272 | |
| Disease | basophil percentage of granulocytes | 9.03e-04 | 83 | 67 | 3 | EFO_0007995 | |
| Disease | response to venlafaxine | 1.47e-03 | 25 | 67 | 2 | EFO_0006328 | |
| Disease | spontaneous preterm birth | 1.59e-03 | 101 | 67 | 3 | EFO_0006917 | |
| Disease | creatinine measurement | 1.82e-03 | 995 | 67 | 8 | EFO_0004518 | |
| Disease | chronic kidney disease (biomarker_via_orthology) | 1.85e-03 | 28 | 67 | 2 | DOID:784 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNFTGLVGGPDFAHC | 86 | P30154 | |
| RGHQGEQGLPGFSTS | 926 | Q9UMD9 | |
| CGVGVHFSPGARGLT | 386 | P21709 | |
| GQTSTQPGGSIHFGC | 2481 | Q7Z408 | |
| QNGGSCEPGLHSGFT | 4436 | Q6V0I7 | |
| NVGGGFHHCSSDRGG | 136 | Q96DB2 | |
| TCPAGFQTSVQGLGH | 316 | Q5T5M9 | |
| RGSSAGGCRNHPGTF | 401 | Q9UMQ6 | |
| QGGLPGAVHQNGRCR | 266 | P32239 | |
| GFRAGHACGTGTQPQ | 96 | P0C864 | |
| GFCEAPGNRTQSGNH | 191 | P27701 | |
| PQGHAGCHTSFTGQG | 826 | O14917 | |
| SGPRCQQGSGHGIAE | 4171 | P98160 | |
| GFGQHRPGSGQSSGF | 1101 | Q5D862 | |
| VAHACNPSTLGGRGG | 311 | Q8NHA8 | |
| SGTVASGGNLPGVHC | 16 | Q96II8 | |
| GGCSNHCSVVPGRGI | 1181 | Q9NZR2 | |
| GGPQANGHIESNGVC | 861 | Q96JA1 | |
| GGSQHGPFTGIACGK | 1441 | O75197 | |
| GGTFGFCVASGNGRP | 1141 | Q5VZ46 | |
| ACVPGRAGQHRGSAT | 56 | Q86W56 | |
| GGPGCGGLVTVAHNA | 1426 | P07942 | |
| GHANGQRIGRFCGTF | 96 | Q9UKZ9 | |
| QMRGNPGSHFCGGTL | 46 | P24158 | |
| TGSANGGAHNCRPEV | 101 | O95402 | |
| GQDGPISVHCSAGVG | 1871 | Q13332 | |
| QGNFLPLQCHGSTGF | 966 | Q14112 | |
| DSPQGHGNSRFQFCG | 3341 | O60494 | |
| VHCLGFGPGASGAAA | 26 | Q9BVC3 | |
| REPGGVTQQGCGIHA | 131 | Q5T6F0 | |
| NPTGANLSLFGCHGQ | 466 | Q8N4A0 | |
| RVNTHAGGTGPEGCR | 231 | Q9GZV9 | |
| PTCNVGSKGVGAGNH | 66 | Q86UU0 | |
| AQEGHCRPRGAGGQS | 1381 | Q14767 | |
| VACTEGFSQSHGGRP | 251 | O75578 | |
| VPGRASTFGIHQGSC | 286 | P14616 | |
| HAGNATVCGFSGGLP | 1281 | Q8TEP8 | |
| SGCQGPGHQPSSRVF | 546 | Q5VTJ3 | |
| HACATVGNRGFVFGG | 221 | Q9Y2U9 | |
| LAGGHGVSASRFGPC | 636 | Q9Y613 | |
| ETGCGPHGVTALGQQ | 26 | Q1T7F1 | |
| AHGVASFSLGPCGRG | 211 | P20160 | |
| VACGPGTHFGGELGQ | 631 | Q8IWY4 | |
| GGDFVSPGQQGRISH | 1496 | P21817 | |
| ACSAAGGGPFVNVSN | 316 | Q8TAU0 | |
| PGIGQRNHCSGAGKA | 61 | Q9UJA2 | |
| GSCHIGGNVATNAGG | 196 | Q8N465 | |
| DGCGPSGAGASNVFV | 191 | Q8IVF1 | |
| DGCGPSGAGASNVFV | 191 | A6NNL0 | |
| QHFTAGPGRASGVTC | 351 | Q8IZ69 | |
| GGCFPGSATVHLEQG | 196 | Q15465 | |
| QPCQAHLGAKGGSSG | 116 | A8MWV9 | |
| QNGGRTCAALPGGLH | 1781 | A2VEC9 | |
| GPCSVSCGGGHQSRQ | 2566 | A2VEC9 | |
| GAAGGTACVLTGQPF | 16 | Q9Y619 | |
| GAAGGTACVLTGQPF | 16 | Q9BXI2 | |
| ITVPGNFQGHSGAQC | 326 | Q08945 | |
| PQRRSFGGGCHVTAA | 116 | Q9NRA8 | |
| GHPGAAQRGQGDLQC | 391 | Q8NFZ5 | |
| HGGSGFVGGLCQVAA | 306 | Q9UID3 | |
| HRQQQEAPAGGGGCS | 61 | Q8NBP0 | |
| SGDQGRCGPTHQGSE | 106 | Q9BVS5 | |
| PSKRGTVGAGCGFNQ | 521 | O14924 | |
| GGHNSSSRNDPCRGG | 801 | Q8N7X1 | |
| GGHLGGQAVGTPNCV | 111 | Q96PX9 | |
| HRQESGFSCKGPGQN | 1291 | P35916 | |
| APGQNGTSFHGCIRN | 1296 | O94813 | |
| AHACNPSTLGGQGGR | 476 | Q99959 | |
| GSQCGEAFSQIPGHN | 11 | O60384 | |
| PAVLGAQGFGAGRHC | 271 | Q9H2S5 | |
| LGTGAGAAGSPAQQH | 96 | Q9GZV5 | |
| TNVGSHCRGRGGDQP | 526 | Q70EL1 | |
| CGHNFQAGELGPGTI | 151 | Q9UPR5 |